Cannara Biotech (TSXV:LOVE) Price-to-Tangible-Book : 0.90 (As of May. 24, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Price-to-Tangible-Book?

As of today (2024-05-24), Cannara Biotech's share price is C$0.79. Cannara Biotech's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was C$0.88. Hence, Cannara Biotech's Price to Tangible Book Ratio of today is 0.90.

The historical rank and industry rank for Cannara Biotech's Price-to-Tangible-Book or its related term are showing as below:

TSXV:LOVE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.89 Med: 1.82 Max: 3.35
Current: 0.9

During the past 6 years, Cannara Biotech's highest Price to Tangible Book Ratio was 3.35. The lowest was 0.89. And the median was 1.82.

TSXV:LOVE's Price-to-Tangible-Book is ranked better than
87.04% of 864 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs TSXV:LOVE: 0.90

A closely related ratio is called PB Ratio. As of today, Cannara Biotech's share price is C$0.79. Cannara Biotech's Book Value per Sharefor the quarter that ended in Feb. 2024 was C$0.88. Hence, Cannara Biotech's P/B Ratio of today is 0.90.

Cannara Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Cannara Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Price-to-Tangible-Book Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.34

1.83

2.32

1.77

1.13

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.07	1.34	1.13	0.89	1.11

Competitive Comparison of Cannara Biotech's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Price-to-Tangible-Book falls into.

Cannara Biotech Price-to-Tangible-Book Calculation

Cannara Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Feb. 2024 )
	=	0.79	/	0.881
	=	0.90

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cannara Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives